| Dr Alexander - Mahendran, MD,FACC | |
|
158 Pomfret St, Putnam, CT 06260-1800 | |
| (860) 928-3958 | |
| (860) 928-2052 |
| Full Name | Dr Alexander - Mahendran |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 158 Pomfret St, Putnam, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154352516 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 017690 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alexander - Mahendran, MD,FACC 158 Pomfret St, Putnam, CT 06260-1800 Ph: (860) 928-3958 | Dr Alexander - Mahendran, MD,FACC 158 Pomfret St, Putnam, CT 06260-1800 Ph: (860) 928-3958 |
News Archive
The U.S. Food and Drug Administration today issued final guidance to help manufacturers who are developing safe and effective cell-based viral vaccines to address emerging and pandemic threats.
The chaperone protein Grp94 can interfere with the clearance of another protein known to cause the glaucoma when mutated, a new study led by researchers at the University of South Florida has found. Using a cell model, the researchers also demonstrated that a new specific inhibitor of Grp94 facilitates clearance of the genetically-defective protein, called myocilin, from cells.
Medison Pharma has concluded an agreement with the medical device company Brainsway for exclusive marketing and distribution of the Deep TMS (Transcranial Magnetic Stimulation) system in Israel.
UCB, a multinational biopharmaceutical company, and Genpact, a global leader in designing, transforming, and running intelligent business operations, have received the Aecus Innovation Award in recognition of their close collaboration in driving transformation that achieved far-reaching operational efficiencies in UCB's global business services (GBS) finance organization.
Prescriptions for an FDA-approved treatment for opioid addiction have increased over the past decade in all age groups except the youngest (age 15-24), a new analysis of prescription data by researchers at Columbia University Irving Medical Center has found.
› Verified 8 days ago
Livinus Okafor, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 320 Pomfret St, Putnam, CT 06260 Phone: 860-928-6541 | |
John A Day, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 320 Pomfret St, Putnam, CT 06260 Phone: 860-928-4344 Fax: 860-928-4188 | |
Dr. Bradford Gillon, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 320 Pomfret St, Putnam, CT 06260 Phone: 860-928-6541 | |
Lisa T Canter, MD,FACC Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 37 Kennedy Drive, Suite A, Putnam, CT 06260 Phone: 860-963-7519 Fax: 860-963-0668 | |
Dr. Mahboob Ashraf, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 320 Pomfret St, Putnam, CT 06260 Phone: 860-928-6541 Fax: 860-963-6450 | |
Alejandro Carvajal, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 320 Pomfret St, Putnam, CT 06260 Phone: 860-928-6541 |